These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 28131641)

  • 1. Retrospective comparative analysis of cardiovascular implantable electronic device infections with and without the use of antibacterial envelopes.
    Hassoun A; Thottacherry ED; Raja M; Scully M; Azarbal A
    J Hosp Infect; 2017 Mar; 95(3):286-291. PubMed ID: 28131641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.
    Shariff N; Eby E; Adelstein E; Jain S; Shalaby A; Saba S; Wang NC; Schwartzman D
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):783-9. PubMed ID: 25845917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
    Tarakji KG; Mittal S; Kennergren C; Corey R; Poole JE; Schloss E; Gallastegui J; Pickett RA; Evonich R; Philippon F; McComb JM; Roark SF; Sorrentino D; Sholevar D; Cronin E; Berman B; Riggio D; Biffi M; Khan H; Silver MT; Collier J; Eldadah Z; Wright DJ; Lande JD; Lexcen DR; Cheng A; Wilkoff BL;
    N Engl J Med; 2019 May; 380(20):1895-1905. PubMed ID: 30883056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.
    Mittal S; Shaw RE; Michel K; Palekar R; Arshad A; Musat D; Preminger M; Sichrovsky T; Steinberg JS
    Heart Rhythm; 2014 Apr; 11(4):595-601. PubMed ID: 24333543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
    Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope.
    Bloom HL; Constantin L; Dan D; De Lurgio DB; El-Chami M; Ganz LI; Gleed KJ; Hackett FK; Kanuru NK; Lerner DJ; Rasekh A; Simons GR; Sogade FO; Sohail MR;
    Pacing Clin Electrophysiol; 2011 Feb; 34(2):133-42. PubMed ID: 20942819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency.
    Pecha S; Aydin MA; Yildirim Y; Sill B; Reiter B; Wilke I; Reichenspurner H; Treede H
    Europace; 2013 Aug; 15(8):1205-9. PubMed ID: 23426553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac implantable electronic device infection in patients with end-stage renal disease.
    Guha A; Maddox WR; Colombo R; Nahman NS; Kintziger KW; Waller JL; Diamond M; Murphy M; Kheda M; Litwin SE; Sorrentino RA
    Heart Rhythm; 2015 Dec; 12(12):2395-401. PubMed ID: 26253036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection.
    Calderón-Parra J; Sánchez-Chica E; Asensio-Vegas Á; Fernández-Lozano I; Toquero-Ramos J; Castro-Urda V; Royuela-Vicente A; Ramos-Martínez A
    Rev Esp Cardiol (Engl Ed); 2019 Oct; 72(10):806-812. PubMed ID: 30340923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CIED infection with either pocket or systemic infection presentation--complete device removal and long-term antibiotic treatment; long-term outcome.
    Ihlemann N; Møller-Hansen M; Salado-Rasmussen K; Videbæk R; Moser C; Iversen K; Bundgaard H
    Scand Cardiovasc J; 2016; 50(1):52-7. PubMed ID: 26485501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis.
    Koerber SM; Turagam MK; Winterfield J; Gautam S; Gold MR
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):609-615. PubMed ID: 29364546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redo procedures and chronic renal dysfunction are associated with higher risk of cardiac electronic device infections.
    Morani G; Mugnai G; Bolzan B; Morosato M; Tomasi L; Ferrari S; Vassanelli C
    Minerva Cardioangiol; 2018 Jun; 66(3):225-232. PubMed ID: 29308851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
    Rizwan Sohail M; Henrikson CA; Jo Braid-Forbes M; Forbes KF; Lerner DJ
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):231-9. PubMed ID: 25243484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects.
    Kolek MJ; Patel NJ; Clair WK; Whalen SP; Rottman JN; Kanagasundram A; Shen ST; Saavedra PJ; Estrada JC; Abraham RL; Ellis CR
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1111-6. PubMed ID: 26222980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients.
    Kolek MJ; Dresen WF; Wells QS; Ellis CR
    Pacing Clin Electrophysiol; 2013 Mar; 36(3):354-61. PubMed ID: 23252988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection control in implantation of cardiac implantable electronic devices: current evidence, controversial points, and unresolved issues.
    Korantzopoulos P; Sideris S; Dilaveris P; Gatzoulis K; Goudevenos JA
    Europace; 2016 Apr; 18(4):473-8. PubMed ID: 26516219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epicardial pacemaker as a bridge for pacemaker-dependent patients undergoing explantation of infected cardiac implantable electronic devices.
    Al-Maisary SSA; Romano G; Karck M; De Simone R
    J Card Surg; 2019 Jun; 34(6):424-427. PubMed ID: 31017328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species.
    Le KY; Sohail MR; Friedman PA; Uslan DZ; Cha SS; Hayes DL; Wilson WR; Steckelberg JM; Baddour LM;
    Am J Cardiol; 2012 Oct; 110(8):1143-9. PubMed ID: 22762715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up.
    Mittal S; Wilkoff BL; Kennergren C; Poole JE; Corey R; Bracke FA; Curnis A; Addo K; Martinez-Arraras J; Issa ZF; Redpath C; Moubarak J; Khelae SK; Boersma LVA; Korantzopoulos P; Krueger J; Lande JD; Morss GM; Seshadri S; Tarakji KG
    Heart Rhythm; 2020 Jul; 17(7):1115-1122. PubMed ID: 32087357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study.
    Deharo JC; Quatre A; Mancini J; Khairy P; Le Dolley Y; Casalta JP; Peyrouse E; Prévôt S; Thuny F; Collart F; Raoult D; Habib G; Franceschi F
    Heart; 2012 May; 98(9):724-31. PubMed ID: 22523057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.